Results 41 to 50 of about 9,567,257 (308)

Oral mucosal lesions during SARS-CoV-2 infection: a case series and literature review

open access: yesThe Egyptian Journal of Otolaryngology, 2022
Background The most common manifestations of infection with COVID-19 are fever, sore throat, dry cough, headache, and body aches. The available evidence for successful and safe pharmacological therapy against COVID-19 has not yet been identified, and the
Mohammad Salah Mahmoud   +6 more
doaj   +1 more source

Malawi: The impact of COVID-19 and food system responses

open access: yes, 2021
Malawi, like other southern African countries, has endured several waves of infection since the COVID-19 pandemic started. The disease has had severe effects on the economy, including the agriculture sector.
COVID-19 Hub
core   +1 more source

Möglichkeiten und Grenzen der Covid-19-Modellierung

open access: yesMonitor Versorgungsforschung, 2021
„Viele dieser mathematischen Modelle, das sehen wir auch jetzt bei Covid-19, betrachten die Pandemie unabhängig davon, wie das menschliche Verhalten – als Antwort auf das Infektionsgeschehen – sich ändert.
Peter Stegmaier
doaj   +1 more source

Lightning can strike twice: recurrent multiple evanescent white dot syndrome (MEWDS) following both COVID-19 vaccination and subsequent COVID-19 infection

open access: yesJournal of Ophthalmic Inflammation and Infection, 2023
Multiple evanescent white dot syndrome has been reported to occur following COVID-19 vaccination and also secondary to COVID-19 infection. Increasingly, patients are querying their risk from further vaccination against COVID-19, vaccination for other ...
Hannah W. Ng, Rachael L. Niederer
doaj   +1 more source

Mögliche Kollateralschäden von Covid-19 im Fokus

open access: yesMonitor Versorgungsforschung, 2021
Dass die Corona-Epidemie mit ihrer ersten und zweiten Covid-19-Welle auch zu verminderten Leistungsinanspruchnahmen im ambulanten wie stationären Sektor geführt hat, ist zumindest für die erste Welle mit Zahlen belegt – dafür haben vor allem ...
Dr. Eberhard Thombansen, Peter Stegmaier
doaj   +1 more source

A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19

open access: yes, 2021
BACKGROUND: Sarilumab (anti-interleukin-6 receptor-α monoclonal antibody) may attenuate the inflammatory response in Covid-19. METHODS: We performed an adaptive, phase 2/3, randomized, double-blind, placebo-controlled trial of intravenous sarilumab 200 ...
DiCioccio, A. Thomas   +39 more
core   +1 more source

Diabetes in COVID-19 patients: challenges and possible management strategies

open access: yesThe Egyptian Journal of Bronchology, 2021
Background The recent pandemic of coronavirus disease 19 (COVID-19) has been causing intense stress among the global population. In the case of hospitalized and ICU-admitted COVID-19 patients with comorbidities, it has been observed that a major portion ...
Riyan Al Islam Reshad   +6 more
doaj   +1 more source

Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal

open access: yesClinical Case Reports, 2021
COVID‐19 has been linked to a number of cutaneous symptoms in COVID‐19 patients. Although herpes zoster (HZ) was the first sign of COVID‐19 infection in several patients, cases of HZ after COVID‐19 vaccination are rare.
Sangam Shah   +5 more
doaj   +1 more source

Perioperative safety during Covid-19 pandemic: A review article

open access: yesBali Journal of Anesthesiology, 2020
Introduction: Coronavirus disease 2019 (Covid-19) has become a pandemic all over the world. Despite our familiarity with various protection devices, the high incidence among medical personnel is still worrisome.
Tjokorda Gde Agung Senapathi   +4 more
doaj   +1 more source

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

open access: yes, 2022
BACKGROUND: The effectiveness of fluvoxamine to shorten symptom duration or prevent hospitalization among outpatients in the US with mild to moderate symptomatic coronavirus disease 2019 (COVID-19) is unclear. DESIGN: ACTIV-6 is an ongoing, decentralized,
Boulware, David R.   +27 more
core   +1 more source

Home - About - Disclaimer - Privacy